To review the evidence and answer the questions: Does pharmacotherapy for dementia syndromes improve cognitive symptoms and outcomes? Does pharmacotherapy delay cognitive deterioration or delay disease onset of dementia syndromes? Are certain drugs, including alternative medicines (non-pharmaceutical), more effective than others? Do certain patient populations benefit more from pharmacotherapy than others? What is the evidence base for the treatment of ischemic vascular dementia (VaD)?